Skip to content

The VIGOR Study - Virtual Immersive Gaming to Optimize Recovery in Low Back Pain

The VIGOR Study - Virtual Immersive Gaming to Optimize Recovery in Low Back Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03463824
Acronym
VIGOR
Enrollment
154
Registered
2018-03-13
Start date
2019-01-10
Completion date
2023-10-14
Last updated
2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain, Fear of Injury, Fear of Pain

Brief summary

This study will measure the effects of interactive, whole-body video games on movement behavior in people with chronic low back pain.

Detailed description

A fundamental clinical problem in individuals with chronic low back pain is the significant alteration in movement patterns that restrict lumbar spine motion. This restriction of lumbar motion is particularly evident in patients with kinesiophobia; that is, a fear of movement due to possible injury or reinjury. For chronic back pain patients with kinesiophobia it is critical to develop an effective intervention to increase spine motion while minimizing concerns of pain and harm. Accordingly, we have developed a innovative video games that track whole-body motion and are designed to encourage spinal flexion while reducing concerns of pain and harm among individuals with low back pain. Our games have two distinct advantages. First, within this video game environment, visual feedback can be altered by changing the feedback gain of a given movement (e.g., the magnitude of a given joint movement could appear on screen as either larger or smaller than the actual movement). Thus, gain manipulation will result in progressively larger amounts of lumbar spine flexion during game play. Second, video games are potent distractors that can reduce attention to pain.

Interventions

Participants will complete 18 intervention visits over 9 weeks with the number of sessions tapered across weeks (i.e., 3 sessions/week in weeks 1-3, 2 sessions/week in weeks 4-6, and 1 session/week in weeks 7-9).

Participants will complete 18 intervention visits over 9 weeks with the number of sessions tapered across weeks (i.e., 3 sessions/week in weeks 1-3, 2 sessions/week in weeks 4-6, and 1 session/week in weeks 7-9).

Sponsors

Ohio University
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The principal investigators, the statistician, and members of the data collection team will remain blinded to intervention assignment throughout the duration of the study. They will be given the identifying codes only at the end of the study when it is necessary to interpret the results. The un-blinded study coordinator, who is responsible for scheduling testing and treatment sessions, will serve to receive the study patients and escort them to the various testing and treatments sites to minimize the interaction between patients; however, the study coordinator will not participate in the assessments.

Intervention model description

Participants will be randomly assigned to one of two intervention arms. Both intervention arms involve immersive video games that encourage participants to produce progressively larger lumbar flexion excursions at each game level and across treatment sessions. The two groups are distinguished by the amount of lumbar flexion needed to achieve game objectives. One is a control group and the other is the experimental.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 18-60 years of age * Low back pain that has been ongoing for at least half the days in the last 6 months * Average pain intensity of greater than 3 over the past week on a 0-10 Numerical Rating Scale * Disability greater than 4 on Roland and Morris Disability Questionnaire * Agrees with statement It is not really safe for a person with my back problem to be physically active or Tampa Scale of Kinesiophobia score greater than 36 * Has sought care or consultation from a health care provider for back pain * Meets category 1, 2, or 3 on the Classification System of the Quebec Task Force on Spinal Disorders which reflects low back pain without neurological signs * Working proficiency in English

Exclusion criteria

* Has a personal history of the following neurological disorders: Alzheimers, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Parkinsons, Neuropathy, Stroke, Seizures * Has a personal history of the following cardiorespiratory disorders: Congestive heart failure, heart attack in past 2 years * Has a personal history of the following musculoskeletal disorders: Rheumatoid Arthritis, Muscular Dystrophy, pathologic fractures of the spine, avascular necrosis or osteonecrosis, severe osteoarthritis * History of spine surgery or a hip arthroplasty * Has active cancer * Has a chronic disease that may restrict movement or preclude safe participation * Has used opioids within 30 days prior to study enrollment * Reports being pregnant, lactating, or that they anticipate becoming pregnant within 2-months * Reports pending litigation related to CLBP * Has current drug or alcohol use or dependence that, in the opinion of the PIs, would interfere with adherence to study requirements * Has significant visual impairment that would prevent virtual reality headset use * Has significant motion sickness that would prevent virtual reality headset use

Design outcomes

Primary

MeasureTime frameDescription
Percent Change in Pain Reduction on The Numerical Pain Rating Scale (NPRS)Baseline measure through the 48-weeks post-treatment measureThe Numerical Pain Rating Scale (NPRS) is a pain assessment tool that uses a 11 point scale of 0-10 to help patients rate the intensity of their pain: 0: No pain and 10: The worst pain imaginable. The NPRS is the most commonly used unidimensional pain scale. It can be administered verbally or graphically, and patients are asked to select the number that best reflects their pain intensity over the past 24 hours. The smaller the number (closer to 0), the less pain the subject is enduring, and the larger the number, the more pain they are enduring. Percent change in NPRS rather than raw score change may provide more meaningful information regarding a patient's response to pain treatment.
Change in Disability Using the Roland Morris Disability QuestionnaireBaseline measurement through 48-weeks post-treatment measurement changeRoland Morris Disability Questionnaire: A patient taking the survey agrees or disagrees with these statements (Yes/No). The patient is asked to tick a statement when it applies to him that specific day, this makes it possible to follow changes in time. The end score is the sum of the ticked boxes. The items of the questionnaire are assessed on a 0-10 numeric rating scale in which 0 means no disability and 10 is maximum disability. The sum of the seven items equals the total score of the PDI, which ranges from 0 to 70, with higher scores (closer to 70) reflecting higher interference of pain with daily activities and a lower score (closer to 0) has less interference of pain with daily activities.. Test-retest reliability 24-item: intraclass correlation (ICC) ranges from 0.42 - 0.91 T

Countries

United States

Participant flow

Participants by arm

ArmCount
Experimental Group 1
Participants will produce progressively larger lumbar flexion excursions at each game level and across treatment sessions. Experimental Group 1: Participants will complete 18 intervention visits over 9 weeks with the number of sessions tapered across weeks (i.e., 3 sessions/week in weeks 1-3, 2 sessions/week in weeks 4-6, and 1 session/week in weeks 7-9).
74
Experimental Group 2
Participants will produce progressively larger lumbar flexion excursions at each game level and across treatment sessions. Experimental Group 2: Participants will complete 18 intervention visits over 9 weeks with the number of sessions tapered across weeks (i.e., 3 sessions/week in weeks 1-3, 2 sessions/week in weeks 4-6, and 1 session/week in weeks 7-9).
80
Total154

Baseline characteristics

CharacteristicExperimental Group 2TotalExperimental Group 1
Age, Customized41.1 years39.05 years37 years
Median BMI26.7 kg/m^228.3 kg/m^229.9 kg/m^2
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
12 Participants26 Participants14 Participants
Race (NIH/OMB)
Black or African American
24 Participants49 Participants25 Participants
Race (NIH/OMB)
More than one race
4 Participants4 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants4 Participants0 Participants
Race (NIH/OMB)
White
35 Participants70 Participants35 Participants
Radiating pain
no
29 Participants51 Participants22 Participants
Radiating pain
yes
51 Participants103 Participants52 Participants
Region of Enrollment
United States
80 participants154 participants74 participants
Sex: Female, Male
Female
50 Participants100 Participants50 Participants
Sex: Female, Male
Male
30 Participants54 Participants24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 740 / 80
other
Total, other adverse events
4 / 743 / 80
serious
Total, serious adverse events
0 / 740 / 80

Outcome results

Primary

Change in Disability Using the Roland Morris Disability Questionnaire

Roland Morris Disability Questionnaire: A patient taking the survey agrees or disagrees with these statements (Yes/No). The patient is asked to tick a statement when it applies to him that specific day, this makes it possible to follow changes in time. The end score is the sum of the ticked boxes. The items of the questionnaire are assessed on a 0-10 numeric rating scale in which 0 means no disability and 10 is maximum disability. The sum of the seven items equals the total score of the PDI, which ranges from 0 to 70, with higher scores (closer to 70) reflecting higher interference of pain with daily activities and a lower score (closer to 0) has less interference of pain with daily activities.. Test-retest reliability 24-item: intraclass correlation (ICC) ranges from 0.42 - 0.91 T

Time frame: Baseline measurement through 48-weeks post-treatment measurement change

Population: Subjects that completed this procedure

ArmMeasureValue (MEAN)Dispersion
Experimental Group 1Change in Disability Using the Roland Morris Disability Questionnaire37 score on Roland Morris Disability QuestiStandard Deviation 34.6
Experimental Group 2Change in Disability Using the Roland Morris Disability Questionnaire25 score on Roland Morris Disability QuestiStandard Deviation 35.2
Primary

Percent Change in Pain Reduction on The Numerical Pain Rating Scale (NPRS)

The Numerical Pain Rating Scale (NPRS) is a pain assessment tool that uses a 11 point scale of 0-10 to help patients rate the intensity of their pain: 0: No pain and 10: The worst pain imaginable. The NPRS is the most commonly used unidimensional pain scale. It can be administered verbally or graphically, and patients are asked to select the number that best reflects their pain intensity over the past 24 hours. The smaller the number (closer to 0), the less pain the subject is enduring, and the larger the number, the more pain they are enduring. Percent change in NPRS rather than raw score change may provide more meaningful information regarding a patient's response to pain treatment.

Time frame: Baseline measure through the 48-weeks post-treatment measure

Population: Study participants who completed this procedure

ArmMeasureValue (MEAN)Dispersion
Experimental Group 1Percent Change in Pain Reduction on The Numerical Pain Rating Scale (NPRS)30.3 percentage change (NPRS)Standard Deviation 43.2
Experimental Group 2Percent Change in Pain Reduction on The Numerical Pain Rating Scale (NPRS)35.2 percentage change (NPRS)Standard Deviation 33

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026